137 related articles for article (PubMed ID: 317549)
1. Levamisole in the treatment of Hodgkin's disease.
Berényi E; Kávai M; Szabolcsi M; Szegedi G
Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
[TBL] [Abstract][Full Text] [Related]
2. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
Ramot B; Biniaminov M; Shoham C; Rosenthal E
N Engl J Med; 1976 Apr; 294(15):809-11. PubMed ID: 1082545
[TBL] [Abstract][Full Text] [Related]
3. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
Levo Y; Rotter V; Ramot B
Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
[TBL] [Abstract][Full Text] [Related]
4. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
[TBL] [Abstract][Full Text] [Related]
5. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
[TBL] [Abstract][Full Text] [Related]
6. Management of advanced Hodgkin's disease in remission.
Klener P; Hausner P; Donner L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):213-7. PubMed ID: 6179821
[TBL] [Abstract][Full Text] [Related]
7. [E-RFC (T cells) and Ig-positive cells (B cells) in the peripheral blood of patients with lymphogranulomatosis and possible immunocorrection with levamisole].
Markova TP; Danilova NV
Ter Arkh; 1985; 57(7):15-8. PubMed ID: 3876611
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
Basch CM; Spitler LE; Engleman EG; Engleman EP
J Rheumatol; 1977; 4(4):377-88. PubMed ID: 604477
[TBL] [Abstract][Full Text] [Related]
9. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
[TBL] [Abstract][Full Text] [Related]
10. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
Pozsonyi T; Jakab L; Fehér J
Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
[TBL] [Abstract][Full Text] [Related]
11. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
Björkholm M; Holm G; Mellstedt H
Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
[TBL] [Abstract][Full Text] [Related]
12. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
[TBL] [Abstract][Full Text] [Related]
13. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
Karande AA; Gulwani B; Advani SH; Gangal SG
Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
[TBL] [Abstract][Full Text] [Related]
14. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
Bodolay E; Berényi E; Sonkoly I; Szegedi G
Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
[TBL] [Abstract][Full Text] [Related]
15. Immunological study of patients with Hodgkin's disease in long-lasting not-maintained complete remission.
Gobbi M; Fiacchini M; Tomasini I; Ruggero D; Lauria F; Tura S
Boll Ist Sieroter Milan; 1977 Mar; 56(2):144-51. PubMed ID: 326273
[TBL] [Abstract][Full Text] [Related]
16. Quantitative study of T and B lymphocytes in Hodgkin's disease.
Bensa JC; Micouin C; Schaerer R; Sotto JJ; Hollard D
Biomedicine; 1977 Apr; 26(2):137-44. PubMed ID: 326312
[TBL] [Abstract][Full Text] [Related]
17. Monocyte chemotaxis and effect of levamisole in Hodgkin's disease.
Lukács K; Frendl G; Berényi E; Kávai M; Szabó G; Szegedi G
Acta Med Acad Sci Hung; 1980; 37(2):145-50. PubMed ID: 7457021
[TBL] [Abstract][Full Text] [Related]
18. [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)].
Lang JM; Bigel P; Giron C; Faradji A; Oberling F; Mayer S
Nouv Presse Med; 1979 Nov; 8(44):3629-32. PubMed ID: 316521
[TBL] [Abstract][Full Text] [Related]
19. [Immune profile in patients with Hodgkin's disease in long-term remission after cytostatic chemotherapy].
Nagel GA; Pietra CD; Hartmann D; Rosenthal M; Albrecht R; Obrist R; Obrecht P
Schweiz Med Wochenschr; 1979 Jan; 109(2):45-51. PubMed ID: 311514
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations.
Pozsonyi T; Fehér J; Jakab L
Allergol Immunopathol (Madr); 1981; 9(1):37-44. PubMed ID: 6973266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
